Barnes Group Inc. (B)
| Bid | 47.45 |
| Market Cap | 2.42B |
| Revenue (ttm) | 1.62B |
| Net Income (ttm) | -39.8M |
| EPS (ttm) | -0.78 |
| PE Ratio (ttm) | -60.87179487179487 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 47.87 |
| Volume | 1,306,923 |
| Avg. Volume (20D) | 756,610 |
| Open | 47.49 |
| Previous Close | 47.46 |
| Day's Range | 47.48 - 47.50 |
| 52-Week Range | 32.65 - 47.50 |
| Beta | 1.34 |
About B
Barnes Group Inc. provides engineered products, industrial technologies, and solutions in the United States and internationally. It operates in two segments: Industrial and Aerospace. The Industrial segment offers precision components, products, and systems used by various customers in end-markets, such as mobility, industrial equipment, automation, personal care, packaging, electronics, and medical devices. This segment also designs and manufact...
Analyst Forecast
According to 3 analyst ratings, the average rating for B stock is "Hold." The 12-month stock price forecast is $47.5, which is an increase of 0.04% from the latest price.
Stock Forecasts
2 months ago · businesswire.com
Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials ConferenceBERWYN, Pa.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic s...
